Zoetis Inc. $ZTS Shares Acquired by Dash Acquisitions Inc.

Dash Acquisitions Inc. boosted its holdings in shares of Zoetis Inc. (NYSE:ZTS) by 55.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 51,534 shares of the company’s stock after acquiring an additional 18,371 shares during the quarter. Zoetis comprises 1.5% of Dash Acquisitions Inc.’s holdings, making the stock its 21st largest holding. Dash Acquisitions Inc.’s holdings in Zoetis were worth $7,418,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of ZTS. Brighton Jones LLC grew its holdings in shares of Zoetis by 180.4% in the fourth quarter. Brighton Jones LLC now owns 4,629 shares of the company’s stock valued at $754,000 after purchasing an additional 2,978 shares in the last quarter. Empowered Funds LLC boosted its position in Zoetis by 6.2% in the 1st quarter. Empowered Funds LLC now owns 11,293 shares of the company’s stock valued at $1,859,000 after buying an additional 657 shares during the period. Intech Investment Management LLC grew its stake in shares of Zoetis by 17.2% in the first quarter. Intech Investment Management LLC now owns 8,347 shares of the company’s stock worth $1,374,000 after acquiring an additional 1,224 shares in the last quarter. Sivia Capital Partners LLC increased its position in shares of Zoetis by 73.8% during the second quarter. Sivia Capital Partners LLC now owns 3,348 shares of the company’s stock worth $522,000 after acquiring an additional 1,422 shares during the period. Finally, Sheets Smith Wealth Management raised its stake in shares of Zoetis by 6.5% in the second quarter. Sheets Smith Wealth Management now owns 1,712 shares of the company’s stock valued at $267,000 after acquiring an additional 104 shares in the last quarter. Institutional investors and hedge funds own 92.80% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Bank of America cut Zoetis from a “buy” rating to a “neutral” rating and set a $135.00 price objective for the company. in a research note on Monday, December 15th. Morgan Stanley set a $160.00 target price on shares of Zoetis in a report on Thursday, December 18th. KeyCorp initiated coverage on shares of Zoetis in a report on Thursday, November 20th. They set a “sector weight” rating for the company. Wall Street Zen upgraded shares of Zoetis from a “hold” rating to a “buy” rating in a report on Friday. Finally, Stifel Nicolaus decreased their price objective on shares of Zoetis from $140.00 to $130.00 and set a “hold” rating for the company in a research report on Tuesday, November 18th. Five analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average target price of $152.91.

Trending Headlines about Zoetis

Here are the key news stories impacting Zoetis this week:

• Positive Sentiment: Seeking Alpha publishes a contrarian bullish take calling Zoetis “undervalued and oversold,” arguing the recent pullback creates a buying opportunity for long-term investors. Zoetis: Undervalued And Oversold
• Positive Sentiment: Wall Street Zen upgraded ZTS to a “Buy,” providing short-term bullish analyst support that can attract investors looking for rebound trades. Zoetis (NYSE:ZTS) Upgraded by Wall Street Zen to “Buy” Rating
• Positive Sentiment: Zacks and other research note Zoetis’ strong earnings-surprise history and flag a reasonable chance the company could beat upcoming estimates — a potential catalyst to re-rate the stock higher if results impress. Will Zoetis (ZTS) Beat Estimates Again in Its Next Earnings Report?
• Positive Sentiment: Coverage noting a roughly 24% one‑year pullback frames ZTS as a value/opportunity trade for investors focused on long-term fundamentals and steady margins. Is Zoetis (ZTS) Offering An Opportunity After A 24% One-Year Share Price Pullback
• Neutral Sentiment: Analyst consensus remains middling: an aggregate “Hold”/average recommendation that signals neither broad optimism nor widespread pessimism from the Street. Zoetis Inc. (NYSE:ZTS) Given Average Recommendation of “Hold” by Analysts
• Neutral Sentiment: Benzinga’s roundup of eight analyst notes highlights mixed views and varied price targets — useful context but not a single decisive catalyst. 7ZTS : What 8 Analyst Ratings Have To Say About Zoetis
• Negative Sentiment: Piper Sandler downgraded ZTS from Overweight to Neutral and cut its price target from $190 to $135 — a material reduction in upside that likely pressured the stock and sentiment. Piper Sandler Downgrades Zoetis to Neutral (StreetInsider)

Zoetis Trading Down 0.3%

Shares of Zoetis stock opened at $124.04 on Friday. Zoetis Inc. has a 1 year low of $115.25 and a 1 year high of $177.40. The company has a debt-to-equity ratio of 1.31, a quick ratio of 2.28 and a current ratio of 3.64. The company has a market capitalization of $54.66 billion, a P/E ratio of 20.88, a PEG ratio of 2.16 and a beta of 0.97. The company’s fifty day moving average is $123.58 and its two-hundred day moving average is $138.43.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Tuesday, November 4th. The company reported $1.70 earnings per share for the quarter, topping analysts’ consensus estimates of $1.62 by $0.08. The company had revenue of $2.40 billion during the quarter, compared to analysts’ expectations of $2.42 billion. Zoetis had a return on equity of 57.19% and a net margin of 28.21%.The firm’s revenue for the quarter was up .5% on a year-over-year basis. During the same period last year, the firm earned $1.58 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Analysts forecast that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 3rd. Shareholders of record on Tuesday, January 20th will be given a dividend of $0.53 per share. The ex-dividend date is Tuesday, January 20th. This is an increase from Zoetis’s previous quarterly dividend of $0.50. This represents a $2.12 annualized dividend and a yield of 1.7%. Zoetis’s dividend payout ratio (DPR) is currently 35.69%.

Zoetis Company Profile

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.